Amarin Announces New REDUCE-IT® Data at ACC.23/WCC Showing Benefit of VASCEPA®/VAZKEPA® (Icosapent Ethyl) in High-Risk Patients with a Recent Acute Coronary Syndrome Event

March 5, 2023

https://www.globenewswire.com/news-release/2023/03/05/2620629/18362/en/Amarin-Announces-New-REDUCE-IT-Data-at-ACC-23-WCC-Showing-Benefit-of-VASCEPA-VAZKEPA-Icosapent-Ethyl-in-High-Risk-Patients-with-a-Recent-Acute-Coronary-Syndrome-Event.html

–Post-Hoc Analysis Shows IPE Significantly Reduced Risk of First, Total Ischemic Events by 37% and 36% Respectively in Patients with Recent ACS Without Increased Bleeding–

Read more at globenewswire.com

Related news for (AMRN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.